Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Aug 15, 2017; 9(8): 327-332
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.327
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.327
Table 1 Clinicopathological characteristics of the two groups n (%)
Group A (n = 109) | Group B (n = 83) | P value | |
Age, median [IQR], yr | 66 [61-74] | 72 [63-78] | 0.0009 |
Male | 92 (84.4) | 72 (86.7) | 0.7 |
Diabetes mellitus | 24 (22.0) | 12 (14.5) | 0.2 |
Complicated other malignant disease | 27 (24.8) | 22 (26.5) | 0.9 |
Helicobacter pylori status | 0.4 | ||
Positive | 82 | 57 | |
Post eradicated | 23 | 26 | |
Negative | 4 | 0 | |
Tumor location | 0.9 | ||
Upper | 10 | 11 | |
Middle | 57 | 39 | |
Lower | 42 | 33 | |
Tumor size, median [IQR], mm | 15 [10-20] | 15 [12-22] | 0.3 |
Macroscopic type | 0.5 | ||
0-I | 9 | 3 | |
0-IIa | 67 | 52 | |
0-IIb | 26 | 25 | |
0-IIc | 7 | 3 | |
Differentiated type | 109 (100) | 81 (97.6) | 0.2 |
Tumor depth | 0.1 | ||
M | 97 | 80 | |
SM | 12 | 3 |
- Citation: Shibukawa N, Ouchi S, Wakamatsu S, Wakahara Y, Kaneko A. Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer. World J Gastrointest Oncol 2017; 9(8): 327-332
- URL: https://www.wjgnet.com/1948-5204/full/v9/i8/327.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i8.327